Which tumors may cause elevated Carcinoembryonic Antigen (CEA) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tumors That Can Cause Elevated CEA Levels

All of the listed tumors (breast cancer, colorectal cancer, gastric cancer, and lung cancer) may cause elevated CEA levels. 1, 2, 3

CEA in Colorectal Cancer

  • CEA is the marker of choice for monitoring metastatic colorectal cancer during systemic therapy 4
  • Elevated preoperative CEA (≥5 ng/mL) correlates with poorer prognosis in colorectal cancer 4, 5
  • Postoperative CEA monitoring is recommended every 3 months for patients with stage II or III colorectal cancer for at least 3 years after diagnosis 4, 5
  • Despite its utility in monitoring, CEA has high specificity but low sensitivity for colorectal cancer, making it unsuitable for population screening 5

CEA in Breast Cancer

  • CEA levels are elevated in 50-60% of patients with metastatic breast cancer 4
  • CEA can be used for monitoring patients with metastatic breast cancer during active therapy, in conjunction with diagnostic imaging, history, and physical examination 4
  • In breast cancer, CEA elevations may be found in 40-73% of patients presenting with disease in stages I-IV 3
  • Approximately 80% of breast cancer patients will have a CEA elevation 3-10 months prior to clinical symptoms of recurrence 3

CEA in Lung Cancer

  • 77% of patients with bronchogenic lung cancer have elevated preoperative CEA values 3
  • In small cell carcinoma of the lung, CEA levels above 10 ng/ml correlate highly with metastatic disease 3
  • Caution must be exercised when interpreting CEA levels in smokers, as smoking can cause an increase in CEA levels, making differentiation between benign and malignant conditions more difficult 3

CEA in Gastric Cancer

  • Gastric malignancies demonstrate CEA level elevations in just over 50% of cases 3
  • However, these elevations have not been found to be as clinically useful as in colorectal cancer 3

Other Factors Affecting CEA Levels

  • Non-cancer related conditions can also affect CEA levels, including gastritis, peptic ulcer disease, diverticulitis, liver diseases, COPD, diabetes, and inflammatory states 4, 1, 6
  • Certain medications, such as lithium, have been reported to cause reversible CEA elevation 6
  • CEA levels are not influenced by sex, age, blood type, time of blood sampling, or family history of cancer 7

Clinical Application of CEA

  • CEA is not recommended as a standalone diagnostic tool for any cancer type due to its limited sensitivity and specificity 1, 2
  • Markedly increased CEA values (>25 ng/ml) are highly suggestive of metastatic cancer, particularly hepatic metastasis 7
  • CEA levels typically correlate with tumor stage, degree of differentiation, and effectiveness of therapy across various cancer types 3
  • Caution should be used when interpreting a rising CEA level during the first 4-6 weeks of a new therapy, as spurious early rises may occur 4

References

Research

Serum CEA levels in 49 different types of cancer and noncancer diseases.

Progress in molecular biology and translational science, 2019

Research

CEA in tumors of other than colorectal origin.

Seminars in surgical oncology, 1991

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

CEA Levels in Colorectal Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.